File Download
  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: The new NICE Guidelines on the treatment of Hypertension

TitleThe new NICE Guidelines on the treatment of Hypertension
Authors
KeywordsCardiovascular disease
Issue Date2011
PublisherHong Kong College of Cardiology. The Journal's web site is located at http://www.hkcchk.com/journals.php#3
Citation
The 15th Annual Scientific Meeting of the Institute of Cardiovascular Science and Medicine (ICSM), Hong Kong, 17 September 2011. In Journal of the Hong Kong College of Cardiology, 2011, v. 19 n. 2, p. 65, abstract no. PL1 How to Cite?
AbstractIn 2011, American and British guidelines on the management of hypertension are scheduled to be updated. The British guidelines, developed by the National Institute for Clinical Excellence, have just been published in August 2011. There are several significant changes in these guidelines. Ambulatory blood pressure is named the new gold standard in the diagnosis of hypertension. It is valuable not only in people with white coat hypertension, but also in people whose ambulatory blood pressures are higher than blood pressure readings in the clinic. Home blood pressure monitoring is now recognised as being useful and informative. Largely as a result of the ASCOT study, calcium channel blockers (CCB) and blockers of the renin-angiotensin system have surpassed diuretics and beta-blockers as first line drugs. Patients 55 or younger should receive an ACE inhibitor, or an angiotensin receptor blocker if the former is not tolerated. Older patients are started on a CCB. A thiazide diuretic is used as the third drug, but interestingly, chorthalidone and indapamide are preferred as they showed favourable outcomes in large clinical trials. Treatment with these three drug classes should be sufficient in the majority of patients, but if triple therapy is insufficient, referral to a hypertension specialist is recommended. Alpha and beta blockers do not even make fourth place, which is taken up by spironolactone. While the new UK guidelines are controversial, the changes are based on the best available current evidence. In Hong Kong, the prevalence of hypertension has been increasing among young and middle-aged men, and is approaching 50% among the elderly. Current efforts are channelled towards the detection and treatment of hypertension in middle and old age. The linear rise in the prevalence of hypertension with age means that measures to prevent hypertension, such as a healthy diet and regular physical activity, should start early in life.
DescriptionPlenary Lectures
Persistent Identifierhttp://hdl.handle.net/10722/165429
ISSN
2015 SCImago Journal Rankings: 0.102

 

DC FieldValueLanguage
dc.contributor.authorCheung, BMYen_US
dc.date.accessioned2012-09-20T08:18:12Z-
dc.date.available2012-09-20T08:18:12Z-
dc.date.issued2011en_US
dc.identifier.citationThe 15th Annual Scientific Meeting of the Institute of Cardiovascular Science and Medicine (ICSM), Hong Kong, 17 September 2011. In Journal of the Hong Kong College of Cardiology, 2011, v. 19 n. 2, p. 65, abstract no. PL1en_US
dc.identifier.issn1027-7811-
dc.identifier.urihttp://hdl.handle.net/10722/165429-
dc.descriptionPlenary Lectures-
dc.description.abstractIn 2011, American and British guidelines on the management of hypertension are scheduled to be updated. The British guidelines, developed by the National Institute for Clinical Excellence, have just been published in August 2011. There are several significant changes in these guidelines. Ambulatory blood pressure is named the new gold standard in the diagnosis of hypertension. It is valuable not only in people with white coat hypertension, but also in people whose ambulatory blood pressures are higher than blood pressure readings in the clinic. Home blood pressure monitoring is now recognised as being useful and informative. Largely as a result of the ASCOT study, calcium channel blockers (CCB) and blockers of the renin-angiotensin system have surpassed diuretics and beta-blockers as first line drugs. Patients 55 or younger should receive an ACE inhibitor, or an angiotensin receptor blocker if the former is not tolerated. Older patients are started on a CCB. A thiazide diuretic is used as the third drug, but interestingly, chorthalidone and indapamide are preferred as they showed favourable outcomes in large clinical trials. Treatment with these three drug classes should be sufficient in the majority of patients, but if triple therapy is insufficient, referral to a hypertension specialist is recommended. Alpha and beta blockers do not even make fourth place, which is taken up by spironolactone. While the new UK guidelines are controversial, the changes are based on the best available current evidence. In Hong Kong, the prevalence of hypertension has been increasing among young and middle-aged men, and is approaching 50% among the elderly. Current efforts are channelled towards the detection and treatment of hypertension in middle and old age. The linear rise in the prevalence of hypertension with age means that measures to prevent hypertension, such as a healthy diet and regular physical activity, should start early in life.-
dc.languageengen_US
dc.publisherHong Kong College of Cardiology. The Journal's web site is located at http://www.hkcchk.com/journals.php#3-
dc.relation.ispartofJournal of the Hong Kong College of Cardiologyen_US
dc.subjectCardiovascular disease-
dc.titleThe new NICE Guidelines on the treatment of Hypertensionen_US
dc.typeConference_Paperen_US
dc.identifier.emailCheung, BMY: mycheung@hku.hken_US
dc.identifier.authorityCheung, BMY=rp01321en_US
dc.description.naturelink_to_OA_fulltext-
dc.identifier.hkuros208476en_US
dc.identifier.volume19en_US
dc.identifier.issue2en_US
dc.identifier.spage65en_US
dc.identifier.epage65en_US
dc.publisher.placeHong Kong-
dc.description.otherThe 15th Annual Scientific Meeting of the Institute of Cardiovascular Science and Medicine (ICSM), Hong Kong, 17 September 2011. In Journal of the Hong Kong College of Cardiology, 2011, v. 19 n. 2, p. 65, abstract no. PL1-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats